These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 39138071)

  • 1. Addition of nucleotide adjuvants enhances the immunogenicity of a recombinant subunit vaccine against the Zika virus in BALB/c mice.
    Valdes I; Suzarte E; Lazo L; Cobas K; Cabrales A; Pérez Y; Garateix R; Silva JA; Aguilar JC; Guzman CA; Guillén G
    Vaccine; 2024 Nov; 42(25):126213. PubMed ID: 39138071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Critical neutralizing fragment of Zika virus EDIII elicits cross-neutralization and protection against divergent Zika viruses.
    Tai W; He L; Wang Y; Sun S; Zhao G; Luo C; Li P; Zhao H; Fremont DH; Li F; Jiang S; Zhou Y; Du L
    Emerg Microbes Infect; 2018 Jan; 7(1):7. PubMed ID: 29362446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant Zika virus envelope protein elicited protective immunity against Zika virus in immunocompetent mice.
    Liang H; Yang R; Liu Z; Li M; Liu H; Jin X
    PLoS One; 2018; 13(3):e0194860. PubMed ID: 29590178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunization of Zika virus envelope protein domain III induces specific and neutralizing immune responses against Zika virus.
    Yang M; Dent M; Lai H; Sun H; Chen Q
    Vaccine; 2017 Jul; 35(33):4287-4294. PubMed ID: 28669618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Recombinant Subunit Based Zika Virus Vaccine Is Efficacious in Non-human Primates.
    Medina LO; To A; Lieberman MM; Wong TAS; Namekar M; Nakano E; Andersen H; Yalley-Ogunro J; Greenhouse J; Higgs S; Huang YS; Vanlandingham DL; Horton JS; Clements DE; Lehrer AT
    Front Immunol; 2018; 9():2464. PubMed ID: 30467501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Highly Expressing, Soluble, and Stable Plant-Made IgG Fusion Vaccine Strategy Enhances Antigen Immunogenicity in Mice Without Adjuvant.
    Diamos AG; Pardhe MD; Sun H; Hunter JGL; Kilbourne J; Chen Q; Mason HS
    Front Immunol; 2020; 11():576012. PubMed ID: 33343565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zika Virus Envelope Domain III Recombinant Protein Delivered With Saponin-Based Nanoadjuvant From
    Cibulski S; Varela APM; Teixeira TF; Cancela MP; Sesterheim P; Souza DO; Roehe PM; Silveira F
    Front Immunol; 2021; 12():632714. PubMed ID: 33746970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant Chimpanzee Adenovirus Vaccine AdC7-M/E Protects against Zika Virus Infection and Testis Damage.
    Xu K; Song Y; Dai L; Zhang Y; Lu X; Xie Y; Zhang H; Cheng T; Wang Q; Huang Q; Bi Y; Liu WJ; Liu W; Li X; Qin C; Shi Y; Yan J; Zhou D; Gao GF
    J Virol; 2018 Mar; 92(6):. PubMed ID: 29298885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rational Design of Zika Virus Subunit Vaccine with Enhanced Efficacy.
    Tai W; Chen J; Zhao G; Geng Q; He L; Chen Y; Zhou Y; Li F; Du L
    J Virol; 2019 Sep; 93(17):. PubMed ID: 31189716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity and safety of a self-assembling ZIKV nanoparticle vaccine in mice.
    Liu T; Li M; Tian Y; Dong Y; Liu N; Wang Z; Zhang H; Zheng A; Cui C
    Int J Pharm; 2024 Jul; 660():124320. PubMed ID: 38866086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity and protection conferred by an optimized purified inactivated Zika vaccine in mice.
    Lecouturier V; Bernard MC; Berry C; Carayol S; Richier E; Boudet F; Heinrichs J
    Vaccine; 2019 May; 37(20):2679-2686. PubMed ID: 30967310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunization With a Novel Human Type 5 Adenovirus-Vectored Vaccine Expressing the Premembrane and Envelope Proteins of Zika Virus Provides Consistent and Sterilizing Protection in Multiple Immunocompetent and Immunocompromised Animal Models.
    Guo Q; Chan JF; Poon VK; Wu S; Chan CC; Hou L; Yip CC; Ren C; Cai JP; Zhao M; Zhang AJ; Song X; Chan KH; Wang B; Kok KH; Wen Y; Yuen KY; Chen W
    J Infect Dis; 2018 Jul; 218(3):365-377. PubMed ID: 29617816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Humoral and cellular immunity against both ZIKV and poxvirus is elicited by a two-dose regimen using DNA and non-replicating vaccinia virus-based vaccine candidates.
    Zhan Y; Deng Y; Huang B; Song Q; Wang W; Yang Y; Dai L; Wang W; Yan J; Gao GF; Tan W
    Vaccine; 2019 Apr; 37(15):2122-2130. PubMed ID: 30851967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insect cell-produced recombinant protein subunit vaccines protect against Zika virus infection.
    Qu P; Zhang W; Li D; Zhang C; Liu Q; Zhang X; Wang X; Dai W; Xu Y; Leng Q; Zhong J; Jin X; Huang Z
    Antiviral Res; 2018 Jun; 154():97-103. PubMed ID: 29665376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An inactivated recombinant rabies virus displaying the Zika virus prM-E induces protective immunity against both pathogens.
    Jin H; Jiao C; Cao Z; Huang P; Chi H; Bai Y; Liu D; Wang J; Feng N; Li N; Zhao Y; Wang T; Gao Y; Yang S; Xia X; Wang H
    PLoS Negl Trop Dis; 2021 Jun; 15(6):e0009484. PubMed ID: 34086672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant protein based on domain III and capsid regions of zika virus induces humoral and cellular immune response in immunocompetent BALB/c mice.
    Valdes I; Gil L; Lazo L; Cobas K; Romero Y; Bruno A; Suzarte E; Pérez Y; Cabrales A; Ramos Y; Hermida L; Guillén G
    Vaccine; 2023 Sep; 41(40):5892-5900. PubMed ID: 37599141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maternal immunization with a DNA vaccine candidate elicits specific passive protection against post-natal Zika virus infection in immunocompetent BALB/c mice.
    Wang R; Liao X; Fan D; Wang L; Song J; Feng K; Li M; Wang P; Chen H; An J
    Vaccine; 2018 Jun; 36(24):3522-3532. PubMed ID: 29753607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Measles Virus-Based Vaccine Candidate Mediates Protection against Zika Virus in an Allogeneic Mouse Pregnancy Model.
    Nürnberger C; Bodmer BS; Fiedler AH; Gabriel G; Mühlebach MD
    J Virol; 2019 Feb; 93(3):. PubMed ID: 30429338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zika virus-like particle (VLP) based vaccine.
    Boigard H; Alimova A; Martin GR; Katz A; Gottlieb P; Galarza JM
    PLoS Negl Trop Dis; 2017 May; 11(5):e0005608. PubMed ID: 28481898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zika Virus-Like Particles Bearing a Covalent Dimer of Envelope Protein Protect Mice from Lethal Challenge.
    De Lorenzo G; Tandavanitj R; Doig J; Setthapramote C; Poggianella M; Sanchez-Velazquez R; Scales HE; Edgar JM; Kohl A; Brewer J; Burrone OR; Patel AH
    J Virol; 2020 Dec; 95(1):. PubMed ID: 33028720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.